Fort Point Capital Partners LLC Hepion Pharmaceuticals, Inc. Transaction History

Fort Point Capital Partners LLC

  • $803 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.14 - $1.58 $11,399 - $15,800
-10,000 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$1.39 - $2.1 $13,899 - $21,000
10,000 New
10,000 $15,000

About Hepion Pharmaceuticals, Inc.

HEPA Quotes by TradingView
  • Ticker HEPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,229,600
  • Market Cap $51.8M
  • Description
  • Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...
More about HEPA
Track This Portfolio

Track Fort Point Capital Partners LLC Portfolio

Follow Fort Point Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email